Annual Report 2022
Department of Biobank and Tissue Resources
Yasushi Yatabe, Hiromi Sakamoto, Kouya Shiraishi, Makoto Hirata, Taiki Hashimoto, Masumi Tanaka, Shinsuke Shinoda, Yoko Odaka, Noriko Abe, Akiko Sakamoto, Yuka, Nishina, Sayaka Hashimoto, Kazushige Hori, Masahiro Kodaka, Ayumi Iwai, Kahoko Akimoto
Introduction
Since 2002, the NCC Biobank has been working to build and operate a biobank with a catalog database containing high-quality, standardized clinical and pathological information.
The Team and What We Do
The collection status of the blood and tissue samples in the past three years is summarized in Table 1.
In FY2020, sample collection was suspended from March 31 to April 14, 2020 due to COVID-19 pandemic, but the number of new sample collection recovered to the same level as January 2020 in September. The monthly collection status is shown in Figure 1.
Table 1. Status of sample collection for the past three years
Research Activities
The total number of articles published in FY2022 on research using biobank samples was high, with 104 papers and a total impact factor of 754.2 (average 7.46, highest 38.5), suggesting that the biobank has contributed sufficiently to the promotion of translational researches so far (Table 2).
Table 2. Contribution to publishing articles using NCC Biobank samples
Education
We accepted visits and interviews from biobank staff and practitioners from other institutions. In addition, we were actively involved in the management of the National Center Biobank Network (NCBN), and cooperated with Tohoku Megabank and BBJ to build a cross-sectional search system.
Future Prospects
Sample numbers in the NCC biobank has been increased, contributing to increased publishing studies, so our task may be shifted to sustainable maintenance phase of the biobank. We are also discussing that sample preparation and types are changed to be more clinically relevant.